series-c-plus
Stage
3
Investors
About
Aptinyx is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat neurological and neuropsychiatric disorders.
Explore Aptinyx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.